Drug-Resistant TB Cases Becoming More Prevalent In India, IPS Reports

Inter Press Service: India Fights a Tougher TB
“…For many [tuberculosis (TB) patients], lack of proper diagnosis and interrupted dosages are increasing their resistance to available drugs. Drug resistance is human-made — an iatrogenic disease resulting from mismanagement of TB, experts say. Drug-resistant TB can occur as a primary infection or develop during a patient’s treatment. India accounted for the greatest increase in MDR-TB in 2012 with an estimated 64,000 new cases…” (Das, 3/5).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.